Regulation of MLK3 by oxidative stress in colon cancer cells
Regulation of MLK3 by oxidative stress in colon cancer cells
批准号:
9097305
负责人:
Deborah N Chadee
金额:
$44.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-01 至 2019-08-31
关键词:
AffectApoptosisBindingBreast Cancer CellCell DeathCell ProliferationColon CarcinomaColorectal CancerFeedbackGene ExpressionGoalsGrowthHumanHydrogen PeroxideIn VitroInflammationInflammatoryMAP Kinase GeneMAPK Signaling Pathway PathwayMAPK3 geneMAPK8 geneMaintenanceMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of gastrointestinal tractMalignant neoplasm of lungMalignant neoplasm of ovaryMediatingMitogen-Activated Protein Kinase KinasesMitogen-Activated Protein KinasesMitogensNecrosisNormal CellOxidative StressPharmaceutical PreparationsPhosphorylationPhosphotransferasesPhysiologicalProductionProteinsReactive Oxygen SpeciesRegulationRoleSerineSignal PathwaySignal TransductionSignal Transduction PathwayStimulusStressTNF geneThreonineToxinTumor Cell LineUbiquitinationUp-Regulationcancer cellchemotherapeutic agentcytokineirradiationmalignant phenotypemetaplastic cell transformationmigrationmixed lineage kinase 3novelnovel strategiesoverexpressionprotein degradationpublic health relevanceresearch studyresponsescaffold
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Mixed lineage kinase 3 (MLK3) is a serine/threonine mitogen-activated protein kinase (MAP3K) that regulates multiple MAPK signaling pathways in response to mitogenic and stress stimuli. Depending on the cellular context, MLK3 can phosphorylate MKK4 or MKK7 MAPK kinases (MAP2Ks), which activate c-Jun N-terminal Kinase (JNK) to trigger cell death. Alternatively, MLK3, through a kinase-independent scaffold function, can activate B-Raf and extracellular signal-regulated kinase (ERK) signaling to promote cell proliferation. MLK3 is required for the migration and invasion of human ovarian, gastrointestinal, lung, and breast cancer cells. A requirement for MLK3 in mitogen-dependent ERK activation and colon cancer cell proliferation has been demonstrated; however its function in colon cancer cell invasion is not known. Many cancer cells have persistent, intrinsic oxidative stress and higher levels of reactive oxygen species (ROS) than normal cells. Stimuli such as pro-inflammatory cytokines, irradiation, toxins and chemotherapeutic drugs can trigger ROS production. At very high levels ROS can elicit activation of signal transduction pathways and induce apoptosis or necrotic cell death, and at low levels ROS can stimulate cell proliferation. Our preliminary findings indicate that oxidative stress strongly activates ERK1/2 signaling which promotes the phosphorylation of MLK3 in colon cancer cells. Oxidative stress also promotes an ERK-dependent increase in MLK3 protein level and a decrease in MLK3 kinase activity. Furthermore, we demonstrated that ERK could phosphorylate MLK3 in vitro. Thus, we have identified ERK as a novel, positive regulator of MLK3 protein level and a negative regulator of MLK3 kinase activity in response to oxidative stress. We postulate that the enhancement of inactive MLK3 protein in response to oxidative stress could cause persistent MLK3-dependent stimulation of ERK signaling and thereby promote cellular transformation and proliferation of colon cancer cells. The overall goal of this proposal is to define the mechanism by which oxidative stress induces ERK-dependent regulation of MLK3, and elucidate the impact of this regulation on MLK3-dependent stimulation of cellular transformation, proliferation and apoptosis in colon cancer cells. Accordingly the specific aims of the proposal are: 1) To investigate the role of ERK signaling in H202-mediated upregulation of MLK3 in colon cancer cells. 2) To determine the impact of ROS and ERK activation on MLK3 kinase activity and function, 3) To elucidate the function of MLK3 in colon cancer cell proliferation and invasion. The experiments described in this proposal will allow us to gain a thorough understanding of how oxidative stress modulates MLK3 protein level and kinase activity and how this affects MLK3-dependent activation of MAPK signaling, proliferation and invasion of colon cancer cells. Furthermore, we will examine novel strategies to deplete cellular MLK3 protein levels to inhibit colon cancer cell proliferation and invasion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of Cadherins by MLK3
-
批准号:10793060
-
项目类别:
-
资助金额:$45.15万
-
财政年份:2023
-
负责人:Deborah N Chadee
-
依托单位:
Regulation of MLK3 by LATS
-
批准号:10056321
-
项目类别:
-
资助金额:$15.81万
-
财政年份:2019
-
负责人:Deborah N Chadee
-
依托单位:
Regulation of MLK3 by LATS
-
批准号:9811718
-
项目类别:
-
资助金额:$45.07万
-
财政年份:2019
-
负责人:Deborah N Chadee
-
依托单位:
MLK4 regulation of MAPK signaling
-
批准号:8366331
-
项目类别:
-
资助金额:$34.92万
-
财政年份:2012
-
负责人:Deborah N Chadee
-
依托单位:
Regulation of Mixed Lineage Kinase 3 by the tumor suppressor protein Merlin
-
批准号:7364459
-
项目类别:
-
资助金额:$21.6万
-
财政年份:2008
-
负责人:Deborah N Chadee
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: